Emerging Genomic Biomarkers: Impact on Drug Discovery and Clinical Practice

joint with The Molecular and Integrative Basis for Toxic Responses

Organizer(s): Stephen H. Friend, Lawrence J. Lesko and Daniel K. Burns

Summary of Meeting:

This conference will focus on bringing together the developers of genomic technologies with the clinicians expecting to use them, and the regulators charged with ensuring their appropriate usage. We will focus on two themes. The first theme will be to exemplify how diverse methods to track DNA, RNA, and protein changes have come to rely on sophisticated techniques of pattern recognition bringing up questions of how best to validate these methods. The second theme is to contrast the strategies needed to develop disease phenotyping marker from those needed for intermediate response markers and from other markers such as predictive markers.

Scholarship Deadline: January 5 2006

Discounted Abstract Deadline: January 5 2006

Abstract Deadline: March 17 2006

Discounted Registration Deadline: March 17 2006

We gratefully acknowledge additional support for this conference from:

We gratefully acknowledge additional in-kind support for this conference from those foregoing speaker expense reimbursements:

Bristol-Myers Squibb Company

GlaxoSmithKline

Merck Research Laboratories

PPD, Inc.

We appreciate the organizations that provide Keystone Symposia with additional support, such as marketing and advertising:

Click here to view more of these organizations

Special thanks to the following for their support of Keystone Symposia initiatives to increase participation at this meeting by scientists from underrepresented backgrounds:

Click here to view more of these organizations